Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CATHERINE M BROOME

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1669470985
CMS profile
302001
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$160,874.71

60 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $70,689.23 31
Alexion Pharmaceuticals, Inc. $59,865.62 20
ARGENX US, INC. $15,694.86 5
Novartis Pharmaceuticals Corporation $5,737.50 2
RECORDATI_RARE_DISEASES_INC. $5,512.50 1
Janssen Global Services, LLC $3,375.00 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

60 matching records · $160,874.71 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 60 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 60.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
RECORDATI_RARE_DISEASES_INC. $5,512.5012/31/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139161558 CMS
GENZYME CORPORATION $1,647.5012/18/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261155967825 CMS
Alexion Pharmaceuticals, Inc. $76.0511/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110534902 CMS
Alexion Pharmaceuticals, Inc. $84.9911/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110552022 CMS
Alexion Pharmaceuticals, Inc. $64.9811/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110553982 CMS
Alexion Pharmaceuticals, Inc. $14,040.0011/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110555578 CMS
Alexion Pharmaceuticals, Inc. $1,747.5311/07/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110533786 CMS
Alexion Pharmaceuticals, Inc. $456.8611/07/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110537755 CMS
GENZYME CORPORATION $2,307.0010/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622983 CMS
Janssen Global Services, LLC $3,375.0010/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261077590723 CMS
GENZYME CORPORATION $2,307.0009/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622967 CMS
Novartis Pharmaceuticals Corporation $3,375.0009/27/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086617649 CMS
GENZYME CORPORATION $8,238.0009/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622969 CMS
GENZYME CORPORATION $337.6809/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622971 CMS
GENZYME CORPORATION $263.3009/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622973 CMS
ARGENX US, INC. $15,400.0009/25/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142112841 CMS
ARGENX US, INC. $122.1009/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142111085 CMS
ARGENX US, INC. $42.3709/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142102146 CMS
ARGENX US, INC. $28.0709/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142102268 CMS
ARGENX US, INC. $102.3209/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142111073 CMS
GENZYME CORPORATION $1,250.0007/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622977 CMS
GENZYME CORPORATION $1,250.0007/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622979 CMS
Novartis Pharmaceuticals Corporation $2,362.5006/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086617651 CMS
GENZYME CORPORATION $500.0006/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622945 CMS
GENZYME CORPORATION $500.0006/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622947 CMS
GENZYME CORPORATION $11,074.0006/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622995 CMS
GENZYME CORPORATION $63.6006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622997 CMS
GENZYME CORPORATION $307.4006/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622999 CMS
GENZYME CORPORATION $544.8406/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139623001 CMS
GENZYME CORPORATION $16,659.1006/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139623003 CMS
GENZYME CORPORATION $2,636.0006/13/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261155226502 CMS
GENZYME CORPORATION $16.0506/13/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155226504 CMS
GENZYME CORPORATION $250.0005/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622943 CMS
GENZYME CORPORATION $250.0004/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622941 CMS
GENZYME CORPORATION $3,559.5004/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139623017 CMS
Alexion Pharmaceuticals, Inc. $11,700.0004/09/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110544965 CMS
Alexion Pharmaceuticals, Inc. $25.0003/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110531451 CMS
Alexion Pharmaceuticals, Inc. $39.9903/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110532089 CMS
Alexion Pharmaceuticals, Inc. $189.5503/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110532998 CMS
Alexion Pharmaceuticals, Inc. $55.4403/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110538335 CMS
Alexion Pharmaceuticals, Inc. $838.2003/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110554806 CMS
Alexion Pharmaceuticals, Inc. $371.7703/01/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110534526 CMS
Alexion Pharmaceuticals, Inc. $74.7303/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110536086 CMS
Alexion Pharmaceuticals, Inc. $54.8003/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110544325 CMS
Alexion Pharmaceuticals, Inc. $188.6302/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110535458 CMS
Alexion Pharmaceuticals, Inc. $12,090.0002/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110544961 CMS
Alexion Pharmaceuticals, Inc. $4,680.0002/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110551444 CMS
Alexion Pharmaceuticals, Inc. $217.1002/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110553350 CMS
Alexion Pharmaceuticals, Inc. $12,870.0002/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110555082 CMS
GENZYME CORPORATION $1,750.0002/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139622869 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $43,605.70 47
PY2020 $34,166.80 20
PY2021 $13,968.00 10
PY2022 $53,149.07 30
PY2023 $101,673.19 57
PY2024 $160,874.71 60
PY2025 $96,325.52 50

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
CATHERINE M BROOME, NPI 1669470985. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1669470985.
APA 7
IndustryPayments. (2026). CATHERINE M BROOME, NPI 1669470985 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1669470985
Bluebook
CATHERINE M BROOME, NPI 1669470985, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1669470985.

Source: Centers for Medicare & Medicaid Services, Open Payments.